|
|
|
|
|
|
| Thursday, Feb. 16 , 7:30 a.m.-7:30 p.m. |
|
| 7:30 a.m.-9:00 a.m. |
Session I: Concurrent Symposia A
|
| |
CT Angiography and Perfusion: Enhancing Decision Making in the Emergency Department |
| Moderators: |
Wade Smith, San Francisco, California |
| |
Ting-Yim Lee, London, ON, Canada |
| |
Overview of Predictive Capabilitiesof the CTA, CTA Source Image, and CT Perfusion in Acute Ischemic Stroke |
| |
Michael H. Lev, Boston, Massachusetts |
| |
CT Perfusion: Hardware, Software, and Quantitative Perfusion Maps - Present and Future |
| |
Ting-Yim Lee, London, ON, Canada |
| |
Comparison of CT and MRI Imaging Techniques in Acute Stroke |
| |
Peter Schramm, Heidelberg, Germany |
| |
The Clinical Utility of Advanced CT Techniques in the Management of Acute Stroke Results from STOP - Stroke Study |
|
Karen L. Furie, Boston, Massachusetts |
|
Discussion |
| |
|
| 7:30-9:00 a.m. |
Session I: Concurrent Symposia B |
|
Manipulating the Biology of Axonal Outgrowth In the Central Nervous System to Improve Recovery after Stroke |
| Moderators: |
Walter J. Koroshetz, Boston, Massachusetts |
|
Rajiv R. Ratan, White Plains, New York |
|
Inosine as a Promoter of Neural Outgrowth From Bench to Clinical Trial |
|
Larry Benowitz, Boston, Massachusetts |
|
Proteoglycans and Brain Repair |
|
Marty Grumet, Piscataway, New Jersey |
|
Double Inhibition for Benefit in Stroke Inhibiting Inhibition of Neurite Outgrowth |
|
Stephen M. Strittmatter, New Haven, Connecticut |
|
Clinical Trial Designs to Test Stroke Recovery Drugs |
|
Walter J. Koroshetz, Boston, Massachusetts |
|
Discussion |
|
|
| 7:30-9:00 a.m. |
Session I: Concurrent Symposia C |
| |
Getting Ready for Stroke Center Certification |
| Moderator: |
Edward C. Jauch, Cincinnati, Ohio |
|
Overview of Primary Stroke Center Certification Introduction and JCAHO Certification Center |
|
Mark J. Alberts, Chicago, Illinois |
|
Organizing Your Stroke Team |
|
Anne D. Leonard, San Antonio, Texas |
|
Preventing In-hospital Complication of Stroke |
|
Lee H. Schwamm, Boston, Massachusetts |
|
Conducting Research at Your Stroke Center |
|
Joseph P. Broderick, Cincinnati, Ohio |
|
Discussion |
| |
|
| 7:30-9:00 a.m. |
Session I: Concurrent D |
| |
Prevention Oral Abstract Presentations |
| Moderators: |
S. Claiborne Johnston, San Francisco, California |
|
Bruce Ovbiagele, Los Angeles, California |
| 3 |
Intracranial Stenosis, “Failure” of Antithrombotic Therapy, and Risk of Stroke |
|
Lucian Maidan, Emory Univ, Atlanta, GA; Michael Lynn, Rollins School of Public Health, Atlanta, GA; George Cotsonis, Emory Univ, Rollins School of Public Health, Atlanta, GA; Timothy Upchurch, Emory Univ, Atlanta, GA; Steven Levine, Mount Sinai School of Med, New York, NY; Jose Romano, Univ of Miami, Miami, FL; Marc Chimowitz, Emory Univ, Atlanta, GA; for the WASID investigators |
| 4 |
Patient Subgroups in the Randomized SAPPHIRE Study of Carotid Stenting with Distal Protection vs Endarterectomy |
|
Pierre B Fayad, Univ of Nebraska Med Ctr, Omaha, NE; Kenneth Ouriel, Cleveland Clinic Foundation, Cleveland, OH; Marc Wholey, Allegheny Univ Hosp, Cleveland, OH; Barry Katzen, Miami Cardiac and Vascular Inst, Miami, FL; Sidney Cohen, Cordis, Warren, NJ; Jay Yadav, Cleveland Clinic Foundation, Cleveland, OH |
| 5 |
Paradoxical Rebound Platelet Activation After NSAIDS or COX-2 Inhibitor Withdrawal: Which Patients Are at Higher Risk for Vascular Events? |
|
Victor Serebruany, Alex Malinin, HeartDrug Research, Towson, MD; Deepak Bhatt, Cleveland Clinic, Cleveland, OH |
| 6 |
Local TV News Reporting of Stroke: A National Perspective |
|
James M Pribble, Jennifer J Majersik, William G Barsan, Lewis B Morgenstern, Univ of Michigan, Ann Arbor, MI |
| 7 |
Sarpogrerale-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A Randomized, Double-Blind, Aspirin-Controlled Trial |
|
Yukito Shinohara, Ctr for Stroke and Neurological Diseases, Tokai Univ, Tokyo Hosp, Tokyo, Japan; Hideo Tohgi, Iwate Med Univ, Morioka, Japan; Yasuo Fukuuchi, Ashikaga Red Cross Hosp, Ashikaga, Japan; Shinichiro Uchiyama, Tokyo Women's Med Univ, Tokyo, Japan; Takenori Yamaguchi, National Cardiovascular Ctr, Osaka, Japan; Shotai Kobayashi, Shimane Univ Faculty of Med, Izumo, Japan; Eiichi Otomo, Yokufukai Geriatric Hosp, Tokyo, Japan; Fumio Gotoh, Keio Univ, Tokyo, Japan; Shunsaku Hirai, Kunihiko Hayashi, Gunma Univ, Maebashi, Japan; Tohru Sawada, Aino Hosp, Osaka, Japan; Akiro Terashi, Nippon Med School, Tokyo, Japan; Shunnosuke Handa, Tokai Univ, Tokyo, Japan; Kazuoki Kondo, Mitsubishi Pharma Corp, Tokyo, Japan; Katsuya Nishimaru, Fukuoka Univ, Fukuoka, Japan |
| 1 |
1-Year Restenosis After Carotid Stenting in the Lead-in Phase of the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) |
|
Helmi L Lutsep, Oregon Stroke Ctr, OHSU, Portland, OR; George Howard, Virginia J Howard, Jenifer Voeks, Univ of Alabama at Birmingham, Birmingham, AL; Wayne M Clark, Oregon Stroke Ctr, OHSU, Portland, OR; Alice Sheffet, UMDNJ-New Jersey Med School, Newark, NJ; Thomas G Brott, Mayo Clinic Jacksonville, Jacksonville, FL; Robert W Hobson II, UMDNJ-New Jersey Med School, Newark, NJ; for the CREST Investigators |
| 2 |
Low Complication Rates for Carotid Artery Stenting in the Credentialing Phase of the Carotid Revascularization Endarterectomy Versus Stenting Trial |
|
Gary Roubin, Lenox Hill, New York, NY; Wayne Clark, Oregon Stroke Ctr, Portland, OR; Elie Chakhtoura, St Michael's Med Ctr, Newark, NJ; William Brooks, Central Baptist Hosp, Lexington, KY; Robert J Hye, Kaiser Permanente, San Diego, CA; Virginia Howard, Univ of Alabama, Birmingham, AL; Susan Hughes, MeeLee Tom, UMDNJ/New Jersey Med School, Newark, NJ; Jamie Roberts, Mayo Clinic, Jacksonville, FL; Larry B Goldstein, Duke Univ, Durham, NC; Thomas Brott, Mayo Clinic, Jacksonville, FL; Robert W Hobson II, UMDNJ/New Jersey Med School, Newark, NJ |
|
Discussion |
| |
|
| 9:00- 9:10 a.m. |
Break |
| |
|
| 9:10-10:40 a.m. |
Session II: Concurrent Symposia A |
| |
Vascular Cognitive Impairment and Stroke Trials: Time for Meeting of the Minds |
| Moderators: |
Vladimir Hachinski, London, ON, Canada |
| |
Colin P. Derdeyn, St. Louis, Missouri |
| |
The Physiology of Vascular Cognitive Impairment: Atherosclerosis, Blood Pressure, and Cerebral Ischemia |
| |
Randolph S. Marshall, New York, New York |
| |
Failing Heart, Failing Brain? CHF, CABG, and Cognitive Outcomes |
| |
Patrick Pullicino, Newark, New Jersey |
| |
Large and Small Vessel Stroke: Tailoring the Battery to the Disease |
| |
Ronald M. Lazar, New York, New York |
| |
Incorporating Cognitive Outcomes in Stroke Trial Design: Past and Future Measurement |
| |
David Nyenhuis, Chicago, Illinois |
| |
Discussion |
| |
|
| 9:10-10:40 a.m. |
Session II: Concurrent Symposia B |
| |
Beyond Glutamate: Novel Mechanisms and Targets for Ionic Imbalance and Neuroprotection |
| Moderators: |
Michael A. Moskowitz, Charlestown, Massachusetts |
| |
Mark P. Goldberg, St. Louis, Missouri |
| |
Introduction |
| |
Michael A. Moskowitz, Charlestown, Massachusetts |
| |
Transient Receptor Potential Channels and PSD Proteins |
| |
Michael Tymianski, Toronto, Ontario, Canada |
| |
pH-sensitive Channels |
| |
Roger P. Simon, Portland, Oregon |
| |
Proteases and Ion-Exchange Transporters |
| |
Perluigi Nicotera, Leicester, United Kingdom |
| |
Beyond Glutamate: Perspectives and Predictions |
| |
Alastair Buchan, Oxford, United Kingdom |
| |
Discussion |
| |
|
| 9:10-10:40 a.m. |
Session II: Concurrent Symposia C |
| |
Preventing Strokes and Improving Outcomes |
| Moderator: |
Arthur M. Pancioli, Cincinnati, Ohio |
|
Medical Approaches to Stroke Prevention |
|
Larry B. Goldstein, Durham, North Carolina |
|
Surgical and Endovascular Treatments for Stroke Prevention |
|
Ralph L. Sacco, New York, New York |
|
The Role of Nurses and Allied Health Professionals in Stroke Prevention and Recovery |
|
name to come |
|
Advances in Rehabilitation |
|
Richard D. Zorowitz, Philadelphia, Pennsylvania |
|
Discussion |
| |
|
| 9:10-10:40 a.m. |
Session II: Concurrent D |
| |
Thrombolysis Oral Abstract Presentations |
| Moderators: |
Devin L. Brown, Ann Arbor, Michigan |
|
Adnan I Qureshi, Newark, New Jersey |
| 8 |
Efficacy of Microbubble-Enhanced Sonothrombolysis Among Stroke Subtypes |
|
Marta Rubiera, Marc Ribo, Raquel Delgado-Mederos, Esteban Santamarina, Rafael Huertas, Pilar Delgado, Joan Montaner, José Alvarez-Sabín, Carlos A Molina, Hosp vall d´Hebron, Barcelona, Spain |
| 9 |
"Mild Stroke" Should Not Exclude Patients from Thrombolytic Therapy |
|
Nicole R Gonzales, Karen C Albright, Elizabeth A Noser, Aslam M Khaja, Hashem M Shaltoni, Adam Romman, Neal Zimbaldi, Mary S Baraniuk, Lemuel A Moye, James C Grotta, Univ of Texas Med School, Houston, TX |
| 10 |
National US Estimates of rtPA Use: ICD-9 Codes Substantially Underestimate |
|
Dawn Kleindorfer, Christopher Lindsell, Univ of Cincinnati, Cincinnati, OH; Greg White, Tonja Curtis, Johnson and Johnson Inc, New Brunswick, NJ; Lawrence Brass, Yale Univ, New Haven, CT; Walter Koroshetz, Massachusetts General Hosp, Boston, MA; Joseph P Broderick, Univ of Cincinnati, Cincinnati, OH |
| 11 |
Robust Confirmation of Treatment Effect by Baseline Severity-Adjusted End Point Reanalysis of the NINDS-tPA Stroke Trials |
|
Jeffrey L Saver, Banafsheh Yafeh, UCLA Stroke Ctr, Los Angeles, CA |
| 12 |
Vessel Size Explains Gender Differences in Response to Intravenous Thrombolysis for Acute Stroke |
|
David S Liebeskind, Amelia L Laughton, Doojin Kim, Sidney Starkman, Noriko Salamon, J Pablo Villablanca, Jeffrey L Saver, UCLA, Los Angeles, CA |
| 13 |
Microcatheter Contrast Injections During Intra-arterial Thrombolysis Increase Intracranial Hemorrhage Risk |
|
Pooja Khatri, Joseph P Broderick, Jane C Khoury, Janice Carrozzella, Thomas Tomsick, Univ of Cincinnati, Cincinnati, OH; IMS-1 and 2 Investigators |
| 14 |
Acute Stroke Management in the Elderly |
|
Neer Zeevi, Univ of Connecticut, Hartford, CT; Nora Lee, Isaac Silverman, Hartford Hosp, Hartford, CT; Louise McCullough, Univ of Connecticut, Hartford, CT |
|
Discussion |
| |
|
| 10:40-11:10 a.m. |
Exhibits/Break |
|
|
| 11:10 a.m.-12:45 p.m. |
Session III: Plenary Session I |
| Moderators: |
Costantino Iadecola, New York, New York |
|
Philip B. Gorelick, Chicago, Illinois |
| |
Conference Opening |
|
Costantino Iadecola, New York, New York |
|
American Heart Association/American Stroke Association President's Remarks |
|
Robert H. Eckel, Denver, Colorado |
|
Thomas Willis Lecture |
|
Michael A. Moskowitz, Charlestown, Massachusetts |
|
Plenary Symposium |
|
The Asymptomatic Vascular Lesion and Prevention of Stroke: When to Diagnose and When to Treat in 2006 |
| Moderators: |
Thomas G. Brott, Jacksonville, Florida |
|
John D. Barr, Memphis, Tennessee |
|
The Stenotic, Asymptomatic Plaque in the High-risk Patient |
|
Werner Hacke, Heidelberg, Germany |
|
The Unruptured Cerebral Aneurysm |
|
Jean Raymond, Montreal, PQ, Canada |
|
The Unruptured Cerebral Arteriovenous Malformation |
|
Robert D. Brown, Jr., Rochester, Minnesota |
|
The Patient Foramen Ovale |
|
Anthony Furlan, Cleveland, Ohio |
|
|
| 12:45-2:00 p.m. |
Exhibits and Lunch Break |
|
Nursing and Rehabilitation Professions Roundtable Luncheon |
|
(ticket required, seating is limited) |
|
Early Career/ Stroke Leader Luncheon |
|
(ticket required, seating is limited) |
|
|
| 2:00-3:30 p.m. |
Session IV: Concurrent Symposia A |
|
Mother and Child: Increased Risk of Stroke in the Puerperium |
| Moderators: |
Donna M. Ferriero, San Francisco, California |
|
Gabrielle de Veber, Toronto, Ontario, Canada |
|
Clinical Recognition of Ischemic Stroke and Venous Thrombosis in Fetus and Neonate |
|
Meredith R. Golomb, Indianapolis, Indiana |
|
Stroke During Childbirth: More Common Than Thought |
|
Cheryl Bushnell, Durham, North Carolina |
|
Fetal and Neonatal Neuroimaging - Identifying the Stroke as it Happens |
|
Ellen Grant, Boston, Massachusetts |
|
Maternal Risk Factors for Perinatal Stroke |
|
Yvonne Wu, San Francisco, California |
|
Discussion |
|
|
| 2:00-3:30 p.m. |
Session IV: Concurrent Symposia B |
|
Brain Stimulation to Improve Stroke Outcome |
| Moderator: |
Steven C. Cramer, Orange, California |
|
Introduction |
|
Steven C. Cramer, Orange, California |
| |
Stimulation and Motor System Plasticity in Primates |
| |
Randolph J. Nudo, Kansas City, Kansas |
| |
Cortical Stimulation in Human Neurorehabilitation |
| |
Friedhelm Hummel, Tuebingen, Germany |
| |
Repetitive TMS in the Treatment of Stroke |
| |
Alvaro Pascual-Leone, Boston, Massachusetts |
| |
Human Trials of Epidural Motor Cortex Stimulation |
| |
Richard L. Harvey, Chicago, Illinois |
| |
Discussion |
| |
|
| 2:00-3:30 p.m. |
Session IV: Concurrent C |
| |
Hemorrhage Oral Abstract Presentations |
| Moderators: |
Daniel Woo, Cincinnati, Ohio |
|
Gavin W. Britz, Seattle, Washington |
| 15 |
The Increasing Burden of Anticoagulant-Associated Intracerebral Hemorrhage |
|
Matthew L Flaherty, Mary Haverbusch, Padmini Sekar, Brett M Kissela, Dawn Kleindorfer, Charles J Moomaw, Laura Sauerbeck, Joseph P Broderick, Daniel Woo, Univ of Cincinnati, Cincinnati, OH |
| 16 |
Early Hematoma Evacuation After Fibrinolysis in a Porcine Intracerebral Hemorrhage Model Markedly Decreases Proinflammatory Cytokine Gene Expression in Perihematomal White Matter |
|
Kenneth R Wagner, Shauna Beiler, Christian Beiler, Michael J Linke, Gabrielle M de Courten-Myers, Univ of Cincinnati College of Med, Cincinnati, OH |
| 17 |
Safety Profile of Recombinant Factor VIIa in Patients with Intracerebral Haemorrhage |
|
Michael N Diringer, Washington Univ School of Med, St Louis, MO; Daniel Selchen, Trillum Health Ctr, Mississauga, ON, Canada; Stephen Davis, Royal Melbourne Hosp, Parkville, Australia; Stephan A Mayer, Columbia Univ College of Physicians and Surgeons, New York, NY; Nikolai C Brun, Novo Nordisk A/S, Copenhagen, Denmark; Joseph Broderick, Univ of Cincinnati Med Ctr, Cincinnati, OH; Brett E Skolnick, Novo Nordisk Inc, Princeton, NJ; Thorsten Steiner, Univ of Heidelberg, Heidelberg, Germany; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators |
| 18 |
Myocardial Injury in Patients with Intracerebral Hemorrhage Treated with Recombinant Factor VIIa |
|
Rebecca M Sugg, Nicole R Gonzales, Dawn E Matherne, Marc Ribo, Hashem M Shaltoni, Elizabeth A Noser, John Y Choi, Andrei V Alexandrov, James C Grotta, The Univ of Texas--Houston Med School, Houston, TX |
| 19 |
Neuroprotection by Intravenous Human Neural Stem Cell Transplantation in Intracerebral Hemorrhage with Anti-inflammatory and Anti-apoptotic Effects |
|
Kon Chu, Manho Kim, Keun-Hwa Jung, Soon-Tae Lee, Dong-In Sinn, Jeong-Min Kim, Song-Yi Ko, Stroke and Neural Stem Cell Lab, Seoul National Univ Hosp, Seoul, Republic of Korea; Seung U Kim, Brain Disease Res Ctr, Ajou Univ, Suwon, Republic of Korea; Jae-Kyu Roh, Stroke and Neural Stem Cell Lab, Seoul National Univ Hosp, Seoul, Republic of Korea |
| 20 |
A Tool for Predicting Outcome After Spontaneous Supratentorial Intracerebral Haemorrhage |
|
Barbara A Gregson, A David Mendelow, Univ of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom; STICH Investigators |
| 21 |
New York Islands AVM Study: 5-Year AVM Detection Rates and Age-Dependent Incidence of AVM Hemorrhage |
|
C Stapf, C Hofmeister, J H Choi, H Mast, J P Mohr, Stroke Ctr, Columbia Univ, New York, NY; for the New York Islands AVM Study Collaborators |
|
Discussion |
|
|
| 2:00-3:30 p.m. |
Session IV: Concurrent D |
|
In-hospital Treatment Oral Abstracts |
| Moderators: |
Laszlo Csiba, Debrecen, Hungary |
|
Antonio Carolei, Rome, Italy |
| 22 |
Stent-Assisted Angioplasty in Ostium of Vertebral Artery |
|
Bin Du, Ning Ma, Wei-Jian Jiang, Beijing Tiantan Hosp, Beijing, China |
| 23 |
Get With The Guidelines--Stroke Produces Sustainable Improvements in Hospital-Based Acute Stroke Care |
|
Lee H Schwamm, Massachusetts General Hosp, Boston, MA; Kenneth A LaBresh, MassPRO, Waltham, MA; Wenqin Pan, Duke Clinical Res Inst, Durham, NC; Michael Frankel, Emory Univ School of Med, Atlanta, GA; on behalf of the GWTG Steering Committee and Investigators |
| 24 |
Safety and Feasibility of Intra-arterial Autologous Bone Marrow Mononuclear Cell Transplantation in Acute Ischemic Stroke |
|
Gabriel R de Freitas, Univ Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Maria Lúcia F Mendonça, Daniel C Bezerra, Suzana A Silva, Carlos Henrique Falcão, Constantino S Gonzales, Rodrigo C Moreira, Andrea F Haddad, Fabio A Tuche, Pró-Cardíaco Hosp, Rio de Janeiro, Brazil; Daniel P Santos, Charles Andre, Univ Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Claudio T Mesquita, Amarino A Oliveira, Pró-Cardíaco Hosp, Rio de Janeiro, Brazil; Vinicio Elia, Hosp Municipal Miguel Couto, Rio de Janeiro, Brazil; Hans J Dohmann, Pró-Cardíaco Hosp, Rio de Janeiro, Brazil; Radovan Borojevic, Rosália Mendez-Otero, Univ Federal do Rio de Janeiro, Rio de Janeiro, Brazil; Hans Dohmann, Pró-Cardíaco Hosp, Rio de Janeiro, Brazil |
| 25 |
Intracranial Stent-Assisted Angioplasty in Symptomatic Intracranial Stenosis |
|
Wei-Jian Jiang, Thomas W Leung, Xiao-Tong Xu, Bin Du, Yong-Jun Wang, Beijing Tiantan Hosp, Beijing, China |
| 26 |
Prognostic Value of Glucose Levels in Acute Stroke Outcome: GLIA Study |
|
Blanca Fuentes, Exuperio Díez-Tejedor, Hosp Univ La Paz, Madrid, Spain; José Castillo, Hosp Clínico Univ, Santiago de Compostela, Spain; Antonio Dávalos, Hosp Can Ruti, Badalona, Spain; Antonio Gil Nuñez, Hosp Univ Gregorio Marañon, Madrid, Spain; José Vivancos, Hosp Univ La Princesa, Madrid, Spain; José Egido, Hosp Clínico Univ San Carlos, Madrid, Spain; on Behalf of the Stroke Project. Cerebrovascular Diseases Study Group. Spanish Society of Neurology |
| 27 |
Influence of Statin Withdrawal on Acute Ischemic Stroke Outcome: A Randomized Prospective Study |
|
Florentino Nombela, Hosp Univ de la Princesa, Madrid, Spain; Miguel Blanco, Hosp Clínico Univ, Santiago de Compostela, Spain; M A Moro, School of Med, Univ Complutense, Madrid, Spain; Manuel Rodríguez-Yáñez, Rogelio Leira, Hosp Clínico Univ, Santiago de Compostela, Spain; Ignacio Lizasoain, School of Med, Univ Complutense, Madrid, Spain; Mónica Millán, Hosp Germans Trias i Pujol, Badalona, Spain; Joaquin Serena, Hosp Dr Josep Trueta, Girona, Spain; Jose Vivancos Mora, Hosp Univ de la Princesa, Madrid, Spain; Jose Castillo, Hosp Clínico Univ, Santiago de Compostela, Spain |
| 28 |
Use of Lipid-Lowering Agents During Acute Ischemic Stroke Decreases In-Hospital Mortality |
|
Norrina B Allen, Lawrence M Brass, Yale Univ, New Haven, CT; Julie Cerese, Jackie Dostal, Joanne Cuny, Univ HealthSystem Consortium, Oak Brook, IL; Judith H Lichtman, Yale Univ, New Haven, CT |
|
Discussion |
|
|
| 3:30-4:00 p.m. |
Exhibits/Break |
|
|
| 4:00-5:30 p.m. |
Session V: Concurrent Symposia A |
|
Ischemic Stroke Genetics in 2006 |
| Moderators: |
James F. Meschia, Jacksonville, Florida |
|
Jonathan Rosand, Boston, Massachusetts |
|
From Genetics to Therapeutics |
|
Stephen S. Rich, Winston-Salem, North Carolina |
|
Smoking, Genetics, and Stroke: The Smoking Gun |
|
John Cole, Baltimore, Maryland |
|
Monogenic Stroke in Clinical Practice |
|
Martin Dichgans, Munchen, Germany |
|
Decoding the Relevance of PDE4D for Stroke Risk and Potential Therapeutics |
|
Bradford B. Worrall, Charlottesville, Virginia |
|
Update on SWISS and ISGS |
|
James F. Meschia, Jacksonville, Florida |
|
Discussion |
|
|
| 4:00-5:30 p.m. |
Session V: Concurrent Symposia B |
|
Poststroke Depression Research in Survivors and Caregivers |
| Moderators: |
Cheryl E. Weber, Rochester, New York |
|
Joanne H. Evans, Salem, Massachusetts |
|
Stroke Survivor's Poststroke Depression |
|
Julien Bogousslavsky, Lausanne, Switzerland |
|
Caregiver's Depression |
|
Anu Berg, Lappeenranta, Finland |
|
Interventions for Poststroke Depression Focused on Stroke Survivors |
|
Linda S. Williams, Indianapolis, Indiana |
|
Interventions for Stroke Caregiver Depression |
|
Rosemarie B. King, Chicago, Illinois |
|
Discussion |
|
|
| 4:00-5:30 p.m. |
Session V: Concurrent C |
|
Outcomes Oral Abstracts Presentations I: Clinical Epidemiology |
| Moderators: |
Irene Katzan, Cleveland, Ohio |
|
Cheryl Bushnell, Durham, North Carolina |
| 29 |
Lipoprotein-Associated Phospholipase A2 and C-Reactive Protein as Predictors of Stroke Recurrence and Death: The Northern Manhattan Study |
|
Mitchell S Elkind, Kristen Coates, Wanling Tai, Ralph L Sacco, Columbia Univ, New York, NY |
| 30 |
Elevated White Blood Cell Count and Increased Risk for Stroke and Vascular Death in Patients with Symptomatic Intracranial Disease |
|
Bruce Ovbiagele, UCLA School of Med, Los Angeles, CA; Michael J Lynn, Emory Univ School of Public Health, Atlanta, GA; Jeffrey L Saver, UCLA School of Med, Los Angeles, CA; Marc I Chimowitz, Emory Univ School of Med, Atlanta, GA; for the WASID Study Group |
| 31 |
Hemorrhagic Transformation Is Associated with Hyperthermia in Patients with Acute Stroke |
|
Rogelio Leira, Hosp Clínico Univ, Santiago de Compostela, Spain; Mar Castellanos, Hosp Dr Josep Trueta, Girona, Spain; Javier Arenillas, Hosp Germans Trias i Pujol, Badalona, Spain; Florentino Nombela, Hosp de la Princesa, Madrid, Spain; Tomás Sobrino, Hosp Clínico Univ, Santiago de Compostela, Spain; Yolanda Silva, Hosp Dr Josep Trueta, Girona, Spain; Javier Abella, Hosp Clínico Univ, Santiago de Compostela, Spain; Salvador Pedraza, Hosp Dr Josep Trueta, Girona, Spain; María Ángeles Moro, Univ Complutense, Madrid, Spain; José Vivancos, Hosp de la Princesa, Madrid, Spain; Joaquín Serena, Hosp Dr Josep Trueta, Girona, Spain; Antonio Dávalos, Hosp Germans Trias i Pujol, Badalona, Spain; José Castillo, Hosp Clínico Univ, Santiago de Compostela, Spain |
| 32 |
Antiplatelet Use Is Associated with Less Severe Stroke in Patients with No Prior History of Stroke or TIA |
|
Nerses Sanossian, Jeffrey L Saver, Tannaz Razinia, Doojin Kim, Bruce Ovbiagele, UCLA, Los Angeles, CA |
| 33 |
Trends in 30-Day and Long-Term Survival After First-Ever Ischemic Stroke: The Greater Cincinnati/Northern Kentucky Stroke Study, 1993-1994 vs 1999 |
|
Yong-Jin Cho, Ilsan Paik Hosp, Inje Univ, Goyang, Republic of Korea; Dawn Kleindorfer, Jane C Khoury, Charles J Moomaw, Kathleen Alwell, Daniel Woo, Matthew L Flaherty, Pooja Khatri, Joseph P Broderick, Brett M Kissela, Univ of Cincinnati College of Med, Cincinnati, OH |
| 34 |
An Improved Prediction Model for Acute Ischemic Stroke |
|
Karen C Johnston, Douglas P Wagner, Univ of Virginia, Charlottesville, VA; George C Newman, Univ of Wisconsin, Madison, WI; Vincent Thijs, Univ Hosp Leuven, Leuven, Belgium; Souvik Sen, Univ of North Carolina, Chapel Hill, NC; Steven Warach, NIH-NINDS, Bethesda, MD; for the GAIN and Citicoline Investigators |
| 35 |
Cross-Validation of a Simple 3-Point Prediction Rule to Stratify 7-Day Stroke Risk After TIA |
|
S Claiborne Johnston, UCSF Med Ctr, San Francisco, CA; Peter M Rothwell, Stroke Prevention Research Unit, Univ of Oxford, Oxford, United Kingdom; Mai Nguyen-Huynh, UCSF Med Ctr, San Francisco, CA; Matthew Giles, Stroke Prevention Research Unit, Univ of Oxford, Oxford, United Kingdom; Jacob S Elkins, UCSF Med Ctr, San Francisco, CA; Stephen Sidney, Kaiser-Permanente Med Care Plan, Oakland, CA |
|
Discussion |
|
|
| 4:00-5:30 p.m. |
Session V: Concurrent D |
|
Pathophysiology/Thrombosis Oral Abstracts |
| Moderators: |
Gary A Rosenberg, Albuquerque, New Mexico |
|
Jin-Moo Lee, St. Louis, Missouri |
| 36 |
Synergistic Effects of Statins and Dipyridamole on Stroke Protection: Mechanisms Beyond Lipid Lowering and Platelet Inhibition |
|
Hyung-Hwan Kim, Brigham and Women's Hosp, Boston, MA; Zhipeng Zhou, Michael A Moskowitz, Massachusetts General Hosp, Boston, MA; James K Liao, Brigham and Women's Hosp, Boston, MA |
| 37 |
C-Reactive Protein Induced Disruption of the Blood Brain Barrier Is Prevented by Statins: Involvement of Oxidative Stress, Endothelial Contractile Machinery, and Nitric Oxide |
|
Christoph R Kuhlmann, Heiko J Luhmann, Inst of Physiology, Johannes Gutenberg Univ, Mainz, Germany |
| 38 |
Elevated Matrix Metalloproteinase-9 Associated with Transient Ischemic Attack, Stroke, or Death in Patients with Carotid Stenosis |
|
Nikolaj Eldrup, Marie-Louise Grønholdt, Henrik Sillesen, Rigshospitalet, Copenhagen, Denmark; Børge Nordestgaard, Herlev Univ Hosp, Herlev, Denmark |
| 39 |
Phosphodiesterase 4 as Regulator of Brain Infarction and Brain Endothelial Fibrinolysis |
|
Dong Xue, Fan Yang, Shur-Jen Wang, Jeong Kim, Steven Schreiber, Mark Fisher, UCI, Irvine, CA |
| 40 |
Variations in Blood-Brain Barrier Opening in Stroke Demonstrated by Magnetic Resonance Imaging with Contrast Agents of 2 Different Sizes |
|
Tavarekere N Nagaraja, Richard L Croxen, Polly A Whitton, Kelly A Keenan, Joseph D Fenstermacher, Robert A Knight, Henry Ford Health System, Detroit, MI |
| 41 |
Plasminogen Activator Inhibitor Type-1 Expression in Vascular Smooth Muscle and Microvascular Endothelial Cells Is pp60c-src/Mitogen-Activated Kinase/Upstream Stimulatory Factor Dependent and a Potential Target for Stroke Therapy |
|
Paul J Higgins, Albany Med College, Albany, NY |
| 42 |
3-Dimensional High-Resolution Magnetic Resonance Direct Thrombus Imaging: Detection of Carotid AHA Type VIb/c Plaque |
|
Richard Bitar, Univ of Toronto, Sunnybrook and Women's College HSC, Toronto, ON, Canada; General Leung, Susan Crisp, Sunnybrook and Women's College HSC, Toronto, ON, Canada; Sean Symons, Univ of Toronto, Sunnybrook and Women's College HSC, Toronto, ON, Canada; Corwyn Rowsell, Univ of Toronto, Toronto, ON, Canada; Jagdish Butany, Univ of Toronto, Univ Health Network, Toronto, ON, Canada; David Gladstone, D James Sahlas, Regional Stroke Ctr, Sunnybrook and Women’s College HSC, Toronto, ON, Canada; Alexander Kiss, Inst for Clinical Evaluative Sciences, Toronto, ON, Canada; Andrew Nelson, Sunnybrook and Women's College HSC, Toronto, ON, Canada; Robert Maggisano, Sunnybrook and Women’s College HSC, Toronto, ON, Canada; Alan R Moody, Univ of Toronto, Sunnybrook and Women's College HSC, Toronto, ON, Canada |
|
Discussion |
|
|
| 5:30-7:30 p.m. |
Poster Session I/Reception |
|
|
|
| |
|
|
|
|
|
